Volume 10, Number 2, February 2004

SARS-associated Coronavirus Transmission, United States

Elmira T. Isakbaeva,* Nino Khetsuriani,* R. Suzanne Beard,* Angela Peck,* Dean Erdman,* Stephan S. Monroe,* Suxiang Tong,* Thomas G. Ksiazek,* Sara Lowther,*† Indra Pandya- Smith,* Larry J. Anderson,* Jairam Lingappa,* Marc-Alain Widdowson,* and other members of the SARS Investigation Group
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and †McKing Consulting, Atlanta, Georgia, USA

Figure. Detecting severe acute respiratory syndrome–associated coronavirus (SARS-CoV) RNA by reverse transcriptase–polymerase chain reaction (RT-PCR) and SARS-CoV antibodies by enzyme-linked immunosorbent assay (ELISA) in clinical specimens from seven confirmed SARS case-patients, United States, 2003. Circle within circle: blood specimens (same symbol represents both whole blood and serum when both specimens are collected and results are entirely concordant. s, serum; wb, whole blood (symbols are labeled s or wb if either blood or serum was collected). Blocked symbols denote SARS-CoV–positive specimens by ELISA. : respiratory specimens (include np, nasopharyngeal swab; nw, nasal wash; a, nasal aspirate; op, oropharyngeal swab; sp, sputum). □: stool. ◊: urine. Blocked symbols denote SARS-CoV–positive specimens by RT-PCR.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed January 5, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention